Biography: Moira Crowley, MD
- Director, Fetal Consultative Services, UH Rainbow Babies and Children's Hospital
- Director, Neonatal ECMO, UH Rainbow Babies and Children's Hospital
- Co-Medical Director, Neonatal Intensive Care Unit, UH Rainbow Babies and Children's Hospital
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Neonatal/Perinatal Medicine - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - Children's Hospital Of Philadelphia (2007 - 2010)
Residency | Pediatrics
Pediatrics - Children's Hospital Of Philadelphia (2004 - 2007)
University Of Massachusetts Medical School (2004)
Boston College (2000)
Moira A. Crowley, MD, is a neonatologist in the Division of Neonatology and Perinatal Medicine, Director of the Neonatal Extra-Corporeal Membrane Oxygenation (ECMO) Program, Director of Neonatology Consultative Services at University Hospitals Rainbow Babies & Children’s Hospital, and is the Medical Co-Director of the NICU. She is Associate Professor, Pediatrics, Case Western Reserve University School of Medicine.
Dr. Crowley is board certified in pediatrics and neonatal-perinatal medicine. Her special interests include ECMO, surgical treatment in newborns, and newborns affected by in utero opioid exposure. She joined the UH Rainbow Babies & Children’s Hospital staff in 2010.
Dr. Crowley completed her undergraduate studies at Boston College, Boston, Massachusetts. She received her medical degree from the University of Massachusetts Medical School, Worcester, Massachusetts. She completed a residency in pediatrics followed by a fellowship in neonatology/perinatal medicine, both at The Children’s Hospital of Philadelphia.
Dr. Crowley has published chapters in neonatal medicine textbooks and papers in peer-reviewed journals and presented at national neonatal medicine meetings. She is a member of the American Academy of Pediatrics.
Research & Publications
Interventional research of neonatal opioid withdrawal syndrome (NOWS)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Moira Crowley did not disclose any Outside Relationships with Industry.